Linsen Ye

11PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersHuman impacts of climate change and human adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 03, 2026
Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

|Apr 24, 2026
Hepatic Stellate Cell-Specific METTL3 Deficiency Promotes Hepatocellular Carcinoma Progression via BMP10-SMAD1/5/8 Signaling.

|Apr 15, 2026
N6-methyladenosine-mediated up-regulation of ARRB2 regulates intrahepatic cholangiocarcinoma malignant progression and pemigatinib resistance through MAPK and Hippo signaling pathways.

|Nov 28, 2025
FXR-mediated antigen-specific CD8+ T cell enhances antitumor immunity in intrahepatic cholangiocarcinoma.

Shanshan Liu, Zhixing Liang, Lisi Zhu

|Apr 03, 2024
Cold-induced FOXO1 nuclear transport aids cold survival and tissue storage.

Xiaomei Zhang, Lihao Ge, Guanghui Jin

|Nov 24, 2023
Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells.

Siqi Li, Kun Li, Kang Wang

Pageof 2

Frequent Collaborators

4 joint publications

Wei Liu

2 joint publications

Hua Li

2 joint publications

Rongqiang Liu

2 joint publications

Shuqun Cheng